An Institutional Review Board (IRB) is charged with protecting the rights and welfare of people involved in research. The IRB reviews plans for research involving human subjects to assure, both in advance and by periodic review, appropriate steps are taken to protect the rights and welfare of human subjects in the research study. To accomplish this purpose, IRBs review research protocols and related materials (e.g., consent forms, recruitment material, investigator brochures) to ensure the rights and welfare of human research subjects are protected.

Institutions that accept research funding from the federal government must have an IRB to review all research involving human subjects (even if a given research project does not involve federal funds). The Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) set the guidelines and regulations governing human subjects research and IRBs.

General BRI IRB Information

IRB Staff List


The eProtocol system is a web-based submission, review, and approval platform for BRI and VM research studies.  This new product enables investigators, committee members, and research administrators to process and approve all protocol applications online.

Getting Started

All new Institutional Review Board (IRB) study applications are submitted through eProtocol.  Go to and login using the credentials for your primary organization (BRI or VM).  If you have credentials for both, always log in using the same username and password.

If you are collaborating with BRI/VM researchers and require access to eProtocol, contact the Research Protections Department and provide the following information:

  • First and Last Name
  • Phone Number
  • Email Address
  • A brief explanation of why you need access to eProtocol

Here’s what you can expect

  • Smart forms that make research review and data reporting more accurate and straightforward.
  • Rapid resolution of commonly omitted fields via a “check for completeness” feature.
  • In-app updates, ensuring only one current, approved version of your protocol.
  • Actions taken are in real-time and submissions in progress can be viewed by administration for assistance and guidance on the spot.
  • eProtocol applications can be used as models for new applications, reducing repetitive data entry.

Rollout for use of eProtocol

IRB will be implementing a gradual launch of eProtocol beginning January 2017:

  • All new studies will be submitted through eProtocol as of January 2017.
  • All Continuing Reviews (CR) for currently approved studies where BRI IRB is the IRB of record will be submitted through eProtocol as of February 2017.
  • Once a study is first reviewed in eProtocol (at either the initial review or the first CR), all other study related submissions to BRI IRB (e.g. Amendments, Unanticipated Problems, Adverse Events, study closures, etc.) will occur through eProtocol.  Prior to this, paper modifications are still accepted

Keep the following in mind when using the system:

  • We recommend using Google/Chrome, Mozilla/Firefox, or Apple/Safari as your Internet browser.
  • TURN OFF THE POP-UP BLOCKER on your browser.
  • DO NOT USE THE BACK BUTTON ON YOUR BROWSER. To navigate, use the actual hyperlinks on the page to go to a specific location (e.g. click on protocol # to get protocol, or hyperlink “Home” to go to the start page).

Contact the IRB Staff if you have any questions.

Guidance Documents

Researcher Instructions to Use eProtocol